Erythrocyte pathology clearly indicates microcirculatory problems [208, 230, 232, 375], supporting the hypothesis that inadequate microcirculation in Long COVID, leading to ischemia-reperfusion injury, could play a critical role [352]
I explain here
Success depends on: Diet quality Physical activity Sleep Medication adherence Dose optimization Underlying medical conditions No medication can replace sustainable lifestyle changes
Others require a higher dose to get the full appetite-suppressing effect
Sleep deprivation has been linked to adverse effects on hormone levels, as well as on your mood, immune system, productivity, and immune response
Individuals using oral tirzepatide formulations or sublingual tirzepatide face additional bioavailability considerations that make microdose calculations even more complex